Switch to
Predicate | Object |
---|---|
rdf:type | |
calbc:hasCorrelation | |
skos:definition |
MSH: Type IIb hyperlipoproteinemia is caused by mutation in the receptor-binding domain of APOLIPOPROTEIN B-100 which is a major component of LOW-DENSITY LIPOPROTEINS and VERY-LOW-DENSITY LIPOPROTEINS resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and HYPERTRIGLYCERIDEMIA (combined hyperlipidemia).,NCI: A disorder of lipoprotein metabolism characterized by high levels of cholesterol and triglycerides in the blood. It is caused by elevation of low density and very low density lipoproteins.
|
skos:inScheme | |
skos-xl:prefLabel | |
skos-xl:altLabel |
umls-label:A10907192,
umls-label:A16991768,
umls-label:A17693149,
umls-label:A17696001,
umls-label:A20905189,
umls-label:A11977363,
umls-label:A20903272,
umls-label:A12017917,
umls-label:A8375529,
umls-label:A8375925,
umls-label:A10904644,
umls-label:A11991879,
umls-label:A10904638,
umls-label:A10906459,
umls-label:A16999909,
umls-label:A16999910,
umls-label:A16994422,
umls-label:A10905629,
umls-label:A10907197,
umls-label:A16991769,
umls-label:A12020189
|